雜志介紹

Cardiology雜志介紹

《Cardiology》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱(chēng)心臟病學(xué)，本刊主要出版、報(bào)道醫(yī)學(xué)-CARDIAC & CARDIOVASCULAR SYSTEMS領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專(zhuān)業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專(zhuān)業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為1.9，最新CiteScore 指數(shù)為3.4。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Safety and Efficacy of Ticagrelor versus Clopidogrel in East Asian Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Treated with Dual Antiplatelet Therapy: A Meta-Analysis of Randomized Controlled Trials

  Author: Li, Jingyuan; Wang, Qian; Wu, Chunliu; Qu, Xiaoyu; Zhang, Lei; He, Xiaofeng; Ma, Sicong; Qiu, Miaohan; Wang, Xiaozeng

• Indirect comparison of cryoablation and radiofrequency ablation as initial therapy for symptomatic paroxysmal atrial fibrillation: A systematic review and network meta-analysis of randomized controlled trials

  Author: Mao, Yin-jun; Ai, Li-jing; Cai, Ya-hui; Huang, Qun-ying; Yu, Fu-ling; Chen, Jian-xing; Huang, Pin-fang; Wang, Hang

• Serum Human epididymis protein 4 as a prognostic predictor of new onset heart failure among women after acute coronary syndrome: a single-center retrospective study

  Author: Yan, Qiqi; Wu, Liuyang; Song, Jikai; Ye, Lifang; Zhang, Qinggang; Che, Xiaoru; Zhang, Xin; Wang, Lihong

• Differentiation of Atrial Fibrillation and Atrial Fibrillation-Associated Ischemic Stroke Based on Serum Exosome miRNA-seq

  Author: Xie, Yun; Zhou, Lili; Yan, Meiyu; Zhao, Wei; Hu, Zhaoyang

英文介紹

Cardiology雜志英文介紹

'Cardiology' features first reports on original clinical, preclinical and fundamental research as well as 'Novel Insights from Clinical Experience' and topical comprehensive reviews in selected areas of cardiovascular disease. 'Editorial Comments' provide a critical but positive evaluation of a recent article. Papers not only describe but offer critical appraisals of new developments in non-invasive and invasive diagnostic methods and in pharmacologic, nutritional and mechanical/surgical therapies. Readers are thus kept informed of current strategies in the prevention, recognition and treatment of heart disease. Special sections in a variety of subspecialty areas reinforce the journal's value as a complete record of recent progress for all cardiologists, internists, cardiac surgeons, clinical physiologists, pharmacologists and professionals in other areas of medicine interested in current activity in cardiovascular diseases.